Search results
Linda Avey is a founding general partner at Humain Ventures, an Austin, TX-based venture capital firm investing at the intersection of AI and the bioeconomy. Linda has been at the forefront of the digital health movement. As the visionary founder of 23andMe in 2006, her mission to assemble a research repository of genetic and phenotypic data to ...
Linda Avey's work experience includes co-founding and serving as CEO of Precise.ly, Inc. since September 2017. ... Linda Avey obtained a Bachelor of Arts degree in Biology from Augustana University (SD). Linda also attended Stanford Law School in the year 2021, although the details of their degree and field of study are unknown.
Accomplished and highly commercial Data and Digital Transformation leader able to operate… · Experience: LiveFire AI · Education: Bucknell University · Location: New York City Metropolitan ...
30 de nov. de 2023 · NEW YORK, November 30, 2023 – The Human Immunome Project (HIP) is pleased to announce the appointment of Linda Avey to the Board of Directors. “Linda’s scientific expertise and entrepreneurial spirit will be of immediate benefit to the Human Immunome Project as we pursue our mission to decode and model the human immune system,” said Board Chair Jane Metcalfe.
5 de jun. de 2022 · 23andMe was founded in 2006 by Anne Wojcicki, Linda Avey, and Paul Cusenza. Both women studied biology at university and met for the first time at a dinner in 2005. They hatched plans to start a company together, and Avey roped in her former colleague Cusenza. Avey and Cusenza eventually moved on from the company. Anne Wojcicki, 23andMe CEO
13 de dic. de 2013 · Linda Avey, co-founder of 23andMe and CEO of Curious Inc, was in Dublin last week at the launch of the new building for Systems Biology Ireland. She spoke to Claire O'Connell.
6 de mar. de 2012 · Anne graduated from Yale University with a B.S. in biology. Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences.
